| Univariable HR (95% CI) | Multivariable HR (95% CI)a |
---|---|---|
Clinical characteristics | ||
 Age in years | 1.04 (1.02–1.07)* | 1.02 (0.99–1.04) |
 Female gender | 0.81 (0.45–1.47) |  |
 Symptom duration > 12 weeks | 0.83 (0.46–1.50) |  |
 HAQ score | 1.11 (0.69–1.78) |  |
 68-TJC | 1.02 (0.98–1.05) |  |
 66-SJC | 1.06 (1.02–1.10)* | 1.03 (0.99–1.08) |
 CRP mg/L | 1.01 (1.0–1.02)* | 1.00 (0.99–1.01) |
 ESR mm/h | 1.01 (1.0–1.02) |  |
 ACPA-positive | 0.12 (0.05–0.27)* | 0.16 (0.06–0.39)* |
 RF-positive | 0.33 (0.18–0.61)* | 0.80 (0.41–1.6) |